there is a reported interest in exchange-traded funds (etfs) related to the biotech and genomics industries. some outlets have highlighted specific etfs, including those related to crispr gene editing and ark funds, as potential investment opportunities. the coverage suggests a perceived potential for growth in these areas, but the specific etfs and investment strategies being recommended vary across outlets.